Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cerus Corp (NQ: CERS ) 2.330 +0.080 (+3.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cerus Corp < Previous 1 2 3 4 5 Next > Cerus Corporation to Participate in Upcoming Investor Conferences February 10, 2023 From Cerus Corporation Via Business Wire Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought January 19, 2023 The popular growth investor publishes her daily transactions. She keeps buying Tesla as well as some low-priced genetics specialists. Via The Motley Fool S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher January 09, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 09, 2023 Via Benzinga Nasdaq Surges Over 200 Points; Crude Oil Rises 2% January 09, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga Cerus's Return On Capital Employed Overview November 21, 2022 Via Benzinga Recap: Cerus Q4 Earnings February 22, 2022 Cerus (NASDAQ:CERS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cerus beat... Via Benzinga Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Via Benzinga Stocks That Hit 52-Week Lows On Monday January 09, 2023 Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows. Via Benzinga Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update January 09, 2023 From Cerus Corporation Via Business Wire Cerus Corporation to Participate in Upcoming Investor Conferences November 04, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Third Quarter Financial Results November 03, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate November 02, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage November 01, 2022 From Cerus Corporation Via Business Wire Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022 October 20, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting September 26, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency August 12, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range August 04, 2022 From Cerus Corporation Via Business Wire Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 July 21, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors July 05, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Celebrates World Blood Donor Day 2022 June 14, 2022 From Cerus Corporation Via Business Wire Class Of 1997: 25 Years Decades After Their IPOs, Where Are These Companies Now? May 19, 2022 Delivering on a promise is a tough proposition, and to consistently deliver requires excellence on all fronts. Via Benzinga Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range May 05, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets May 03, 2022 From Cerus Corporation Via Business Wire Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross April 25, 2022 From Cerus Corporation Via Business Wire Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022 April 21, 2022 From Cerus Corporation Via Business Wire Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference February 25, 2022 From Cerus Corporation Via Business Wire Cerus's Return On Capital Employed Overview February 23, 2022 According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9... Via Benzinga Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales February 23, 2022 Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood... Via Benzinga Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results February 22, 2022 From Cerus Corporation Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.